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Transport proteins are required to obtain nutrients,
remove waste products and regulate cellular volume and
ion balances. They make a significant contribution to
the relatively small number (< 350) of all known protein
drug targets. Of the 186 human targets for FDA-
approved oral drugs, 24 (13%) are transporters. How-
ever, they remain critically under-researched in the
design of antimalarial interventions. As well as being
excellent targets in their own right, transporters can
provide delivery routes for drugs that target other essen-
tial parasite processes and are involved in mediating
drug resistance. Therefore, there is ample scientific justi-
fication to increase research activity in this area.
For parasite-encoded transporters, well over 100
known or proposed transport protein sequences have
been identified in the P. falciparum genome (termed the
Plasmodium “permeome”), with orthologues for the
majority appearing in the other plasmodial genomes. Of
these, many are considered to have high therapeutic
potential such as 11 channels, 13 P-type ATPases and
11 ABC transporters. Yet, only a handful of the proteins
within the Plasmodium permeome have been charac-
terised in the detail required for assessment of therapeu-
tic targeting. The P. falciparum hexose transporter,
PfHT, is arguably the best studied parasite transporter.
Here are presented recent studies on this potential anti-
malarial target, utilising the rodent P. berghei model to
investigate the physiological importance of D-glucose
transport in transmission and liver life cycle stages and
to generate an in vivo model for testing inhibitors of
PfHT.
Plasmodium parasites may also utilise endogenous
host transporters, offering further targeting opportu-
nities. New evidence from liver stage parasites, using
high-throughput microarray technology to determine
the effect of P. berghei infection on the transcriptional
profile of host liver cells, has identified over 60 host
transport proteins or regulatory subunits that are differ-
entially expressed during the course of infection. These
proteins and the first characterisation of transport across
the host plasma membrane in Plasmodium-infected liver
cells will also be discussed.
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